Thema
Journal Article
261
Genomic alterations
132
genomic alterations
111
Research Support, Non-U.S. Gov't
74
genomic alteration
61
Genomic Alteration
59
Review
55
Genomic alteration
49
Biomarkers, Tumor
42
610
28
Study Type: Interventional
27
EC 2.7.10.1
22
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
22
prognosis
21
next-generation sequencing
19
Phase: Phase 2
18
targeted therapy
18
Next-generation sequencing
17
Prognosis
15
Copy Number Alteration
14
Immunotherapy
13
Research Support, N.I.H., Extramural
13
cancer
13
comprehensive genomic profiling
13
Medical Condition: Locally advanced or metastatic solid tumors determined to harbor specific oncogenic genomic alterations or who are TMB-high as identified by a validated NGS assay MedDRA version: 21.1Level: LLTClassification code 10065147Term: Malignant solid tumorSystem Organ Class: 100000004864 MedDRA version: 21.1Level: LLTClassification code 10065252Term: Solid tumorSystem Organ Class: 100000004864;Therapeutic area: Diseases [C] - Cancer [C04]
12
Medicine
12
Recruitment Status: Not yet recruiting
12
EC 2.7.11.1
11
R
11
Targeted therapy
11
immunotherapy
11
Breast cancer
10
EC 3.6.5.2
10
ErbB Receptors
10
Proto-Oncogene Proteins p21(ras)
10
Recruitment Status: Authorised-recruitment may be ongoing or finished
10
Biology (General)
9
Circulating Tumor DNA
9
Personalized medicine
9
Tumor microenvironment
9
lung cancer
9
Antineoplastic Agents
8
Case Reports
8
Gene signature
8
Liquid biopsy
8
Lung adenocarcinoma
8
NGS
8
Trastuzumab
8
Tumor immune microenvironment
8
precision medicine
8
mehr ...